Adverse drug reaction of SGLT2 inhibitors
Not Applicable
- Conditions
- Health Condition 1: I240- Acute coronary thrombosis not resulting in myocardial infarctionHealth Condition 2: N18- Chronic kidney disease (CKD)Health Condition 3: E08- Diabetes mellitus due to underlying condition
- Registration Number
- CTRI/2024/05/067860
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged =18 years newly initiated on SGLT2 inhibitors as per standard protocol.
Exclusion Criteria
1.Those patients who are already on SGLT2 inhibitors
2.Patients on cancer chemotherapy, retroviral drugs and glucocorticoids
3.Pregnant females and lactating mothers
4.Patients refusing to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate serious and non-serious adverse effects of SGLT2 inhibitors in diabetic and non-diabetic populationTimepoint: 6months,1year,1.5years.
- Secondary Outcome Measures
Name Time Method To analyze the usage of SGLT2 inhibitors as per prescription in diabetic & non-diabetic populationTimepoint: 6months,1year,1.5years.